Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NATIONAL RESEARCH CORP Director's Dealing 2022

Oct 3, 2022

33341_dirs_2022-10-03_a45bd7fb-4e62-4329-b57e-e110757fc3c8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NATIONAL RESEARCH CORP (NRC)
CIK: 0000070487
Period of Report: 2022-09-29

Reporting Person: RAASCH JONA S (COO, NRC Health)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-09-29 Common Stock M 23581 $13.17 Acquired 23581 Direct
2022-09-29 Common Stock F 12318 $40.66 Disposed 11263 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-09-29 Employee Stock Option (Right to Buy) $13.17 M 23581 Disposed 2025-01-06 Common Stock (23581) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 50619 Indirect

Footnotes

F1: This option became fully exercisable on January 6, 2020.